Sale!

NativeLyser Soluble Protein Lysis Buffer

$495.00 $250.00

Catalog #: B2010007 (1 Liter)
NativeLyserTM is a bacterial cell lysis buffer specially formulated to promote the efficient breakdown of bacterial cells while solubilizing and stabilizing the released recombinant proteins. NativeLyser contains a proprietary cocktail of stabilizers that prevent the loss of recombinant proteins during the preparation of cell-free extracts. By preventing denaturation, proteolytic degradation and non-specific protein aggregation, NativeLyserTM creates a protein-friendly environment when recombinant proteins are released from the bacterial cytoplasm. We recommend the use of NativeLyserTM to purify proteins expressed using the NativeFolderTM Bacterial Culture Medium. NativeLyserTM is provided as a 5X concentrated solution (200 mL) that can be diluted with di-water to produce 1L of ready-to-use buffer.

Live Enquiry about this product via Text/SMS: 1-858-900-3210 (8 am – 8 pm PST)

In stock

Description

NativeLyser Soluble Protein Lysis Buffer

Product Data Sheet Download Data Sheet
MSDS Download MSDS
Catalog number: B2010007
Lot number: 0119B0007
Expiration date: 5/24/23
Provided as: 5X concentrate (200 mL)
Storage: -20°C
Buffer: pH 7.5
Protocol Included

 

References

  • Packiam KAR, Ramanan RN, Ooi CW, Krishnaswamy L, Tey BT. Stepwise optimization of recombinant protein production in Escherichia coli utilizing computational and experimental approaches. Appl Microbiol Biotechnol. 2020 Apr;104(8):3253-3266.
  • Satheeshkumar PK. Expression of Single Chain Variable Fragment (scFv) Molecules in Plants: A Comprehensive Update. Mol Biotechnol. 2020 Mar;62(3):151-167.
  • Smolskaya S, Logashina YA, Andreev YA. Escherichia coli Extract-Based Cell-Free Expression System as an Alternative for Difficult-to-Obtain Protein Biosynthesis. Int J Mol Sci. 2020 Jan 31;21(3). pii: E928.
  • Lipinski DM. A Comparison of Inducible Gene Expression Platforms: Implications for Recombinant Adeno-Associated Virus (rAAV) Vector-Mediated Ocular Gene Therapy. Adv Exp Med Biol. 2019;1185:79-83.
  • Powell N, Pantazi E, Pavlidis P, Tsakmaki A, Li K, Yang F, Parker A, Pin C, Cozzetto D, Minns D, Stolarczyk E, Saveljeva S, Mohamed R, Lavender P, Afzali B, Digby-Bell J, Tjir-Li T, Kaser A, Friedman J, MacDonald TT, Bewick GA, Lord GM. Interleukin-22 orchestrates a pathological endoplasmic reticulum stress response transcriptional programme in colonic epithelial cells. Gut. 2020 Mar;69(3):578-590.
  • Temporini C, Colombo R, Calleri E, Tengattini S, Rinaldi F, Massolini G. Chromatographic tools for plant-derived recombinant antibodies purification and characterization. J Pharm Biomed Anal. 2020 Feb 5;179:112920.
  • de Marco A. Recombinant expression of nanobodies and nanobody-derived immunoreagents. Protein Expr Purif. 2020 Apr 11;172:105645.
  • Knight T, Callaghan MU. The role of emicizumab, a bispecific factor IXa- and factor X-directed antibody, for the prevention of bleeding episodes in patients with hemophilia A. Ther Adv Hematol. 2018 Oct 10;9(10):319-334.
  • Bello-Rivero I, Garcia-Vega Y, Duncan-Roberts Y, Vazquez-Blomquistc D, Santana-Milian H, Besada-Perez V, Rios-Cabrera M. HeberFERON, a new formulation of IFNs with improved pharmacodynamics: Perspective for cancer treatment. Semin Oncol. 2018 Jan;45(1-2):27-33.

 

Products Related to NativeLyser Soluble Protein Lysis Buffer